Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Nomogram for individualized prediction of hepatocellular carcinoma occurrence in HCV-cirrhosis (ANRS CO12 CirVir).

Ganne-Carrié N, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, de Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Riachi G, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle C, Dao T, Benhamou Y, Pilette C, Silvain C, Christidis C, Capron D, Bernard-Chabert B, Zucman D, Di Martino V, Trinchet JC, Nahon P, Roudot-Thoraval F; ANRS CO12 CirVir study group.

Hepatology. 2016 Jun 27. doi: 10.1002/hep.28702. [Epub ahead of print]

PMID:
27348075
2.

Adjuvant I-131 Lipiodol After Resection or Radiofrequency Ablation for Hepatocellular Carcinoma.

Schwarz L, Bubenheim M, Gardin I, Huet E, Riachi G, Clavier E, Goria O, Vera P, Scotté M.

World J Surg. 2016 Aug;40(8):1941-50. doi: 10.1007/s00268-016-3502-5.

PMID:
27098539
3.

Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France.

Marcellin P, Zoulim F, Hézode C, Causse X, Roche B, Truchi R, Pauwels A, Ouzan D, Dumortier J, Pageaux GP, Bourlière M, Riachi G, Zarski JP, Cadranel JF, Tilliet V, Stern C, Pétour P, Libert O, Consoli SM, Larrey D.

Dig Dis Sci. 2016 Jan 28. [Epub ahead of print]

PMID:
26821154
4.

Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study.

About F, Oudot-Mellakh T, Niay J, Rabiéga P, Pedergnana V, Duffy D, Sultanik P, Cagnot C, Carrat F, Marcellin P, Zoulim F, Larrey D, Hézode C, Fontaine H, Bronowicki JP, Pol S, Albert ML, Theodorou I, Cobat A, Abel L; ANRS CO20-CUPIC study group.

PLoS One. 2015 Dec 15;10(12):e0145105. doi: 10.1371/journal.pone.0145105. eCollection 2015.

5.

The CUPIC algorithm: an accurate model for the prediction of sustained viral response under telaprevir or boceprevir triple therapy in cirrhotic patients.

Boursier J, Ducancelle A, Vergniol J, Veillon P, Moal V, Dufour C, Bronowicki JP, Larrey D, Hézode C, Zoulim F, Fontaine H, Canva V, Poynard T, Allam S, De Lédinghen V; ANRS CO20 CUPIC Study Group.

J Viral Hepat. 2015 Dec;22(12):1002-10. doi: 10.1111/jvh.12433. Epub 2015 Jul 27.

PMID:
26216230
6.

Reply to "Albumin infusion in cirrhotic patients with non-SBP infections: End of the story?".

Thevenot T, Monnet E, di Martino V; ALB-CIRINF Study Group.

J Hepatol. 2015 Sep;63(3):768-9. doi: 10.1016/j.jhep.2015.05.007. Epub 2015 May 18. No abstract available.

7.

Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.

Hézode C, Fontaine H, Dorival C, Zoulim F, Larrey D, Canva V, De Ledinghen V, Poynard T, Samuel D, Bourliere M, Alric L, Raabe JJ, Zarski JP, Marcellin P, Riachi G, Bernard PH, Loustaud-Ratti V, Chazouilleres O, Abergel A, Guyader D, Metivier S, Tran A, Di Martino V, Causse X, Dao T, Lucidarme D, Portal I, Cacoub P, Gournay J, Grando-Lemaire V, Hillon P, Attali P, Fontanges T, Rosa I, Petrov-Sanchez V, Barthe Y, Pawlotsky JM, Pol S, Carrat F, Bronowicki JP; CUPIC Study Group.

Gastroenterology. 2014 Jul;147(1):132-142.e4. doi: 10.1053/j.gastro.2014.03.051. Epub 2014 Apr 3.

PMID:
24704719
8.

Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN.

Fontaine H, Kahi S, Chazallon C, Bourgine M, Varaut A, Buffet C, Godon O, Meritet JF, Saïdi Y, Michel ML, Scott-Algara D, Aboulker JP, Pol S; ANRS HB02 study group.

Gut. 2015 Jan;64(1):139-47. doi: 10.1136/gutjnl-2013-305707. Epub 2014 Feb 20.

PMID:
24555998
9.

First case of drug rash eosinophilia and systemic symptoms due to boceprevir.

Samain A, Duval-Modeste AB, Joly P, Leblanc C, Massy N, Courville P, Goria O, Riachi G.

J Hepatol. 2014 Apr;60(4):891-3. doi: 10.1016/j.jhep.2013.12.008. Epub 2013 Dec 12.

PMID:
24333861
10.

Kinetics of relapse after pegylated interferon and ribavirin therapy for chronic hepatitis C.

Brochot E, Riachi G, Plantier JC, Guillemard C, Vabret A, Mathurin P, Nguyen-Khac E, Duverlie G; G4 group.

J Med Virol. 2013 Jul;85(7):1191-8. doi: 10.1002/jmv.23592.

PMID:
23918537
11.

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.

Hézode C, Fontaine H, Dorival C, Larrey D, Zoulim F, Canva V, de Ledinghen V, Poynard T, Samuel D, Bourlière M, Zarski JP, Raabe JJ, Alric L, Marcellin P, Riachi G, Bernard PH, Loustaud-Ratti V, Métivier S, Tran A, Serfaty L, Abergel A, Causse X, Di Martino V, Guyader D, Lucidarme D, Grando-Lemaire V, Hillon P, Feray C, Dao T, Cacoub P, Rosa I, Attali P, Petrov-Sanchez V, Barthe Y, Pawlotsky JM, Pol S, Carrat F, Bronowicki JP; CUPIC Study Group.

J Hepatol. 2013 Sep;59(3):434-41. doi: 10.1016/j.jhep.2013.04.035. Epub 2013 May 10.

PMID:
23669289
12.

Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir).

Bourcier V, Winnock M, Ait Ahmed M, Sogni P, Pambrun E, Poizot-Martin I, Chaffaut C, Chevret S, Trinchet JC, Salmon D; ANRS CO13 Hepavih study group; ANRS CO12 Cirvir study group.

Clin Res Hepatol Gastroenterol. 2012 Jun;36(3):214-21. doi: 10.1016/j.clinre.2011.11.002. Epub 2011 Dec 19.

PMID:
22189509
13.

Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.

Nguyen-Khac E, Thevenot T, Piquet MA, Benferhat S, Goria O, Chatelain D, Tramier B, Dewaele F, Ghrib S, Rudler M, Carbonell N, Tossou H, Bental A, Bernard-Chabert B, Dupas JL; AAH-NAC Study Group.

N Engl J Med. 2011 Nov 10;365(19):1781-9. doi: 10.1056/NEJMoa1101214.

14.

Liver mass in a young adult.

Brunel V, Cauliez B, Lacaze L, Riachi G, Gargala G, Francois A, Lavoinne A, Scotté M.

Lancet. 2011 Sep 24;378(9797):1196. doi: 10.1016/S0140-6736(11)61022-2. No abstract available.

PMID:
21943702
15.

Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study.

Henquell C, Guglielmini J, Verbeeck J, Mahul A, Thibault V, Lebray P, Laperche S, Trimoulet P, Foucher J, Le Guillou-Guillemette H, Fouchard-Hubert I, Legrand-Abravanel F, Métivier S, Gaudy C, D'Alteroche L, Rosenberg AR, Podevin P, Plantier JC, Riachi G, Saoudin H, Coppere H, André E, Gournay J, Feray C, Vallet S, Nousbaum JB, Baazia Y, Roulot D, Alain S, Loustaud-Ratti V, Schvoerer E, Habersetzer F, Pérez-Serra RJ, Gourari S, Mirand A, Odent-Malaure H, Garraud O, Izopet J, Bommelaer G, Peigue-Lafeuille H, van Ranst M, Abergel A, Bailly JL.

Infect Genet Evol. 2011 Mar;11(2):496-503. doi: 10.1016/j.meegid.2010.12.015. Epub 2011 Jan 18.

PMID:
21251997
16.

Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort study.

Melin P, Chousterman M, Fontanges T, Ouzan D, Rotily M, Lang JP, Marcellin P, Cacoub P; CheObs Study Group.

Eur J Gastroenterol Hepatol. 2010 Sep;22(9):1050-7. doi: 10.1097/MEG.0b013e328338d9aa.

PMID:
20351554
17.

Late supra-diaphragmatic lymph node recurrence following resection of a fibrolamellar hepatocarcinoma: an unusual case.

Tsilividis B, Huet E, Lubrano J, Lacaze L, Lestrat JP, François A, Riachi G, Scotté M.

Surg Radiol Anat. 2010 Feb;32(2):123-7. doi: 10.1007/s00276-009-0564-1. Epub 2009 Sep 24.

PMID:
19777153
18.

Bleeding gastric vascular ectasia treated by argon plasma coagulation: a comparison between patients with and without cirrhosis.

Lecleire S, Ben-Soussan E, Antonietti M, Goria O, Riachi G, Lerebours E, Ducrotté P.

Gastrointest Endosc. 2008 Feb;67(2):219-25. doi: 10.1016/j.gie.2007.10.016.

PMID:
18226684
19.

Long-term outcome of liver resection for hepatocellular carcinoma in noncirrhotic nonfibrotic liver with no viral hepatitis or alcohol abuse.

Lubrano J, Huet E, Tsilividis B, François A, Goria O, Riachi G, Scotté M.

World J Surg. 2008 Jan;32(1):104-9.

PMID:
18026787
20.

Inflammatory pseudotumor of the liver revealing gynecological Corynebacterium infection.

Bernard M, Marie I, Riachi G, Goria O, Lerebours E, François A, Levesque H, Michel P.

Scand J Gastroenterol. 2005 Jul;40(7):875-7.

PMID:
16109667
Items per page

Supplemental Content

Loading ...
Write to the Help Desk